Theme: Innovative Research in Diabetes Treatment

Diabetes Congress 2017
Past Report of Diabetes Congress 2016

Diabetes Congress 2017

Scientific Sessions

Clinical Diabetes and Diagnostic Approaches

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels.

Diabetic kidney disease is recognized as the leading cause of excess mortality in the population with type 1 diabetes. The prevailing theory is that excess calories are processed via the mitochondria resulting in accumulation of superoxide radicals via the electron transfer chain. Novel Paradigms in Diabetic Complications, Diabetes, Pre-diabetes represents an elevation of plasma glucose above the normal range but below that of clinical diabetes. Prediabetes and Metabolic Syndrome, To better study both the pathogenesis and potential therapeutic agents, appropriate animal models of type 2 diabetes (T2D) mellitus are needed  for Clinical trials on animal models,  sodium glucose co-transport inhibitors act as a novel strategy for the treatment of diabetes mellitus

Type 2 diabetes is by far the most common type of diabetes in adults (>90 percent) and is characterized by hyperglycemia and variable degrees of insulin deficiency and resistance in Clinical presentation and diagnosis of diabetes mellitus in adults.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

 Diabetes Management

People with type 1 or type 2 diabetes are diagnosed with more of some types of cancer -- and are more likely to die from cancer -- than people without diabetes, a new Australian study shows.

The brain is a hugely important organ which helps to be aware of, understand and interact with our surroundings and others.

As with many of our organs, the brain is susceptible to damage as a result of diabetes & brain

Diabetes foot care & management: Foot ulcers and amputations are a major cause of morbidity, disability, as well as emotional and physical costs for people with diabetes. Early recognition and management of independent risk factors for ulcers and amputations can prevent or delay the onset of adverse outcomes.

In Cardiac Resynchronization Therapy Arrhythmias are irregular heart rhythms and can be caused by a variety of reasons, including age, heart damage, medications and genetics. In heart failure patients CRT, or biventricular pacing, is used to help improve the heart’s rhythm and the symptoms associated with the arrhythmia.

Implantable Cardioverter Defibrillator An ICD is a battery-powered device placed under the skin that keeps track of your heart rate. Thin wires connect the ICD to your heart. If an abnormal heart rhythm is detected the device will deliver an electric shock to restore a normal heartbeat if your heart is beating chaotically and much too fast. It is important to understand that the decision to have angioplasty or coronary artery bypass graft (CABG) surgery to treat coronary artery disease (CAD) depends on many different things. A healthful eating pattern, regular physical activity, and often pharmacotherapy are key components of diabetes management. It is best to get vitamins and minerals from the foods you eat. In fact, research has not been able to prove that dietary or herbal supplements (including omega-3 supplements, cinnamon, and other herbs) help to manage diabetes.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Diabetes and its complications

Gastro paresis is a disorder affecting people with both type 1 and type 2 diabetes in which the stomach takes too long to empty its contents (delayed gastric emptying) Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in the blood vessels of the retina. Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar can injure nerve fibers throughout your body, but diabetic neuropathy most often damages nerves in your legs and feet. Currently, diabetic nephropathy is the leading cause of chronic kidney disease in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end-stage renal disease (ESRD) cases in the United States.

Cardiomyopathy is a condition where the heart muscle is abnormal. The main types of cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy. Cardiomyopathy makes it harder for your heart to pump and deliver blood to the rest of your body. Cardiomyopathy can lead to heart failure. Latent autoimmune diabetes in adults (LADA) is a disorder in which, despite the presence of islet antibodies at diagnosis of diabetes, the progression of autoimmune β-cell failure is slow.

Hypoglycemia is a medical emergency that involves an abnormally diminished content of glucose in the blood. Pregnant women who have never had diabetes before but who have high blood glucose (sugar) levels during pregnancy are said to have gestational diabetes. According to a 2014 analysis by the Centers for Disease Control and Prevention, the prevalence of euglycemia gestational diabetes conferences is as high as 9.2%.  High blood pressure or hypertension increases the risk of heart disease and stroke. Hypertension risk factors include obesity, drinking too much alcohol, smoking, and family history. Beta-blockers are a common treatment for hypertension.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Advanced Technologies & Treatments for Diabetes

Blood glucose (blood sugar) monitoring is the main tool you have to check your diabetes control. This check tells you your blood glucose level at any one time. The artificial pancreas bridges the gap between two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). Relatively, a large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% with type 1 diabetes while the remaining 90% with type 2. Insulin administration is essential for type 1 patients while it is required at later stage by the patients of type 2. Current insulin delivery systems are available as transdermal injections which may be considered as invasive. Several non-invasive approaches for insulin delivery are being pursued by pharmaceutical companies to reduce the pain, and hypoglycemic incidences associated with injections in order to improve patient compliance.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

As a prognostic biomarker for progression of diabetic nephropathy, albuminuria fails in terms of sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which diabetic patients are at highest risk for progression. Bhensdadia et al. report proteomic investigations that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone. Excess adiposity is the most important risk factor for the development of insulin resistance and type 2 diabetes (1). However, mechanisms whereby body fat induces insulin resistance in distant tissues are not well understood. Recent evidence indicates that obesity may be an  inflammatory markers.

Related conferences

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Genetics of Diabetes

Several factors have to come together for a person to develop type 2 diabetes. Elements like nutrition and exercise are extremely important. However, type 2 diabetes also has a strong genetic component. Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetic risk for specific subtypes of diabetes

The burden of diabetes is much higher for racial/ethnic minorities than for whites. Minorities have a higher prevalence of diabetes than whites, and some minorities have higher rates of diabetes-related complications and death. Research results help in understanding these disparities and ways to reduce them.

Diabetes, the sixth leading cause of death in the United States, is a chronic disease characterized by persistent hyperglycemia (high blood glucose levels). Significant advances have been made in recent years in relation to the pathogenesis of T2DM. This has significantly improved our knowledge of one of the most serious health threats in the world, allowing identification of genes and pathways involved in the development and progression of the disease. It has recently become possible to acquire molecular and genetic level information from an individual.

Related conference:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Emerging Focus in Diabetes Research

Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.

There are many risk factors for type 2 diabetes such as age, race, pregnancy, stress, certain medications, genetics or family history,  high cholesterol and obesity. However, the single best predictor of type 2 diabetes is overweight or obesity. Almost 90% of people living with type 2 diabetes are overweight or have obesity. People who are overweight or have obesity have added pressure on their body's ability to use insulin to properly control blood sugar levels, and are therefore more likely to develop diabetes. The number of diabetes cases among American adults increased by a third during the 1990s, and additional increases are expected. This rapid increase in the occurrence of diabetes is mostly attributed to the growing prevalence of obesity in the United States.

The Bioinformatics/Computational Biology Service branch will provide basic capabilities to the Joslin Diabetes Center to analyze a wide range of high-throughput data. Housed on-site at the Joslin, the group and associated resources will be available to Joslin investigators and fellows who are either planning high-throughput experiments or need analysis of multi-scale data.

We prospectively followed 51,552 Finnish men and women 25–74 years of age without a history of Parkinson's disease at baseline. History of diabetes and other study parameters were determined at baseline using standardized measurements. Ascertainment of the Parkinson's disease status was based on the nationwide Social Insurance Institution's drug register data. Hazard ratios of incident Parkinson's disease associated with the history of type 2 diabetes were estimated. The entire spectrum of diabesity, including all of its complications–diabetes, elevated blood sugar, blood pressure, and cholesterol–are simply downstream symptoms that result from problems with diet, lifestyle, and environmental toxins interacting with our unique genetic susceptibilities. Bariatric surgery may be an option for adults with severe obesity. Body mass index (BMI), a measure of height in relation to weight, is used to define levels of obesity. Clinically severe obesity is a BMI > 40 or a BMI > 35 with a serious health problem linked to obesity. Such health problems could be type 2 diabetes, heart disease, or severe sleep apnea (when breathing stops for short periods during sleep).

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Transplantation for Diabetes

In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin. Xenotransplantation is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants.

A transplant of the pancreas is usually reserved for those with serious complications. Pancreas transplants are most often done when a patient also receives a new kidney. Beta cell regeneration events pancreas transplant adds little further risk in this situation and offers big benefits. However, transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Endocrinology: Disorders & Treatment

The endocrine system is a network of glands that produce and release hormones that help control many important body functions, especially the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Cell Therapy for Diabetes and Its Complications

Pancreatic β-cells are the target of an autoimmune assault in type 1 diabetes, with invasion of the islets by mononuclear cells in an inflammatory reaction termed “insulitis,” leading to loss of most β-cells after prolonged periods of disease.

Stem cells are essentially undifferentiated cells that can be induced into becoming specialized cells that are tissue- or organ-specific, according to the U.S. National Institutes of Health.

In some cases, such cells are sourced from embryonic tissue. Alternatively, it's possible to derive stem cells from prespecialized adult cells that are then reprogrammed to morph into an undifferentiated state. These are called induced pluripotent stem cells.

Related conferences:

9th Annual Congress and Endocrine Disorders and Therapies September 11-12 2017, Dallas, USA; International Conference on Metabolic Syndromes October 20-22 2016, UAE; 3rd International conference on Gynecology and Obstetrics October 17-19 2016 Dubai, UAE; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, USA;  15th Global Diabetes Summit and Medicare Expo November 14-16, 2016 Dubai, UAE; 3rd Congress on Steroid Research, November 15- 18 2015 USA;  40th Symposium on Hormones and Cell Regulation October 08 - 11 2015 France;   Portugal;  EndoBridge 15–18 October 2015, Turkey; Endocrinology Conferences October 10-12, 2016 Manchester, UK; Obesity Conferences Nov 14-15, 2016 Dubai, UAE





About Conference

Omics International invites all the participants across the globe to attend the 25th Global Diabetes Summit and Medicare Expo on December 11-12, 2016 at Dubai, UAE but with the special focus on the theme Innovative Research in Diabetes Treatment. We believe we have chosen a venue that guarantees a successful scientific Conference.

 

With the success of conference on various clinical, medical and management science, Omics International  is going to organize a conference on 15th Global Diabetes Summit and Medicare Expo. The previous Diabetes congresses were held at Santa Clara-USA, Philadelphia-USA, Hyderabad-India, Chicago-USA and Las Vegas-USA had achieved a grand success. Now it is the time for the diabetes meetings to address new challenges and emerging issues in Diabetes. Diabetes Expo-2016 will also provide the excellent opportunity to meet Physicians, Researchers, Clinicians, Experts, Directors, Professors, Associate Professors, Podiatrists, Pharmacists, Physician assistants, Nurse practitioners, Nurses, Dietitians, Certified diabetes educators, other health care professionals and who manage diabetes related complications.





Market Analysis

  • Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. According to WHO Diabetes was estimated to affect 371 million people till the end of 2011in US. Whereas, new figures indicate that the number of people living with diabetes is expected to rise from 371 million in 2012 to 552 million by 2030. This indicates an urgent alarm for its management.

     
  • "Regionally, we saw the largest increase in diagnosed diabetes prevalence in the South, followed by the West, Midwest, and Northeast," with CDC's Division of Diabetes Translation and lead author of the report. "These data also reinforce findings from previous studies, which indicate that the prevalence of diagnosed diabetes is highest in the southern and Appalachian states."

As the number of patients grows across the globe, there has never been a stronger and more urgent need for therapeutic measures that arrest the growth of the disease and alleviate its secondary manifestations. In Type 1 diabetes total β-cell loss occurs. In Type 2 diabetes, partial β-cell loss occurs before diagnosis, and the progressive β-cell loss during the life of the patient increases the severity of the disease. This addresses novel therapies for these deficiencies in clinical and preclinical evaluation.

Many International Conferences and Diabetic therapies meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents meetings, obesity conferences, weight loss conferences, Islet transplantation international conference, glucose variability conferences etc. Besides that many international events such as diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events, recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases, risk of cancer and intolerability to cure the wound which will gives a better insight about the associated causes and disease portfolio.

Why in Dubai

The UAE has the second-highest diabetes rate in the world, with an estimated 20% of residents and 25% of nationals suffering from the disease. Nearly three-quarters of diabetes patients in the UAE do not have their diabetes under control, a challenge particularly pronounced among children and young adults. It is estimated that 40 to 50% of diabetics in the UAE are unaware they even have the disease. Left unchecked, the spread of diabetes portends devastating social and fiscal consequences, including threats to economic progress and investment stability in the region. 

The United Arab Emirates (UAE) has achieved an impressive level of economic development. In particular, its healthcare sector is among the best performing in the world. By many measures of health status (infant mortality, life expectancy, eradication of numerous infectious diseases), the UAE has reached levels comparable with other developed nations. In addition, the health infrastructure which includes facilities, equipment, and staff, are of high quality. This healthcare is offered freely or at low-cost to citizens and highly subsidised to residents and tourists. The fact that the UAE has made such great strides in achieving a high level of excellence in accommodating the healthcare needs of so many people is a testament to wise resource management policies. However, at least one health pandemic threatens to unravel the system’s stability: diabetes. The World Health Organization (WHO) and the International Diabetes Federation (IDF) call diabetes the 21st century’s leading healthcare challenge. Diabetes complications and mortality create social and economic challenges that affect individuals, families, businesses, and society as a whole. Six Middle East North Africa (MENA) region countries – Bahrain, Egypt, Kuwait, Oman, Saudi Arabia, and the United Arab Emirates (UAE) – are among the world’s 10 highest for prevalence of diabetes and impaired glucose tolerance. By 2020, 32% of the adult UAE population (age 20-79) may have diabetes or pre-diabetes, while other data indicate that the adult UAE population (ages 18 and above) has already reached a diabetes or pre-diabetes rate of 44%. If trends continue, the IDF projects that by 2030, the number of people with diabetes in the Middle East North Africa (MENA) region will almost double, reaching 59.7 million. 

Diabetes Associations

Major Diabetes Associations around the Globe


•    Diabetes Indian Association
•    Canadian Diabetes Association
•    International Diabetes Federation
•    Diabetes Australia
•    Austrian Diabetes Association
•    Diabetes UK
•    Diabetes South Africa
•    Spanish Diabetes Society (Spain)
•    Swedish Diabetes Association
•    Korean Diabetes Association


Major Diabetes Associations in Dubai

•    Emirates diabetes society

•    Global Health Partner Diabetes Centre Dubai

•    Cleveland Clinic Dubai
•    Joslin Diabetes Centre Dubai
•    Al Jalila Foundation Research Centre in Dubai
•    Diabetes Research Institute Dubai

•    Diabetes Education in Tribal Schools (DETS)
•    Imperial College London Diabetes Centre Dubai





Past Conference Report

Diabetes Congress 2016

The 15th Global Diabetes Summit and Medicare Expo (Diabetes Congress-2016) hosted by OMICS Group took place at JW Marriott Dubai during November 14-16, 2016 UAE. It was organized by Conference Series LLC and generous response was received from the Editorial Board Members of Supported Journals as well as from eminent scientists, young and brilliant researchers, business delegates and young student communities. Physicians, Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2016 from OMICS Group. The three day program witnessed thought provoking keynote and plenary presentations from experts in the field of Diabetes and Metabolism, highlighting the theme, “Innovative Research in Diabetes Treatment".

The conference was carried out through various sessions, in which the discussions were held on the following scientific tracks

  • Clinical Diabetes & Diagnostic Approaches
  • Diabetes & its Complications
  • Emerging Focus in Diabetes Research
  • Diabetes Management
  • Transplantation for Diabetes
  • Advanced Technologies & Treatments for Diabetes
  • Genetics of Diabetes
  • Endocrinology: Disorders & Treatment
  • Cell Therapy for Diabetes & Its Complications
  • Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes

The response to 15th Global Diabetes Summit and Medicare Expo was huge and was attended by about 150 attendees from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the Keynote forum.

  • Hamzeh Awad
    Al Khawarizmi International College, UAE
  • Abdelmarouf Hassan Mohieldein
    Qassim University, KSA
  • Fausta Micanti
    University of Naples Federico II, Italy
  • Yazen Joudeh
    Center for Adult & Pediatric Wellness, USA

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions at Diabetes Congress-2016.

All accepted abstracts have been indexed in OMICS Group Journal of Diabetes & Metabolism as a special issue.

We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Diabetes Congress-2016, and with their unique feedback, Conference Series LLC would like to announce the "25th Global Diabetes Summit and Medicare Expo "to be held in Dubai, UAE during December 11-12, 2016.

 


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 11-12, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations